MacroGenics | MGNX - Market Capitalization

Stock Price
3.18
Daily Change
0.11 3.58%
Monthly
34.75%
Yearly
189.09%
Q2 Forecast
2.98

MacroGenics reported $191.7M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
Geron USD 843M 31M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 1.09B 256M Dec/2025